RISCTOX Database
Search and consult detailed information about specific chemical substances.
Search other substances
Identification
- Name:
- indium phosphide
- Synonyms:
-
- fosfuron de indio
- CAS:
- 22398-80-7
- EC/EINECS:
- 244-959-5
- Molecular Formula:
- InP
CLASSIFICATION AND LABELLING (Regulation 1272/2008)
Symbols
-
Respiratory sensitisation
H Phrases
-
H350 : May cause cancer
Carc. (Cat. 1B) : Carcinogenicity
-
H361f : Suspected of damaging fertility.
Repr. (Cat. 2) : Reproductive toxicity
-
H372 : Causes damage to organs through prolonged or repeated exposure
STOT RE (Cat. 1 (pulmones)) : Specific target organ toxicity - repeated exposure
Labelling
| Concentration | Labelling |
|---|---|
| C ≥ 0,1 % | STOT RE 1; H372 |
| C ≥ 0,01 % | Carc 1B; H350 |
| 0,01 % ≤ C < 0,1 % | STOT RE 2; H373 |
Specific health risks
As per IARC ?
Substances classified by the International Agency for Research on Cancer (IARC/WHO) according to their evidence of carcinogenicity in humans. Groups range from 1 (proven human carcinogen) to 4 (probably not carcinogenic to humans). The IARC classification is an international reference in occupational and environmental health.
As per other sources
Carcinogens and mutagens (IARC) ?
Substances classified as carcinogens or mutagens Category 2 under the CLP Regulation (GHS), bearing H351 and/or H341 phrases. These are substances suspected of causing cancer or heritable genetic mutations in humans.
Carcinogens (other sources) ?
Substances classified as carcinogens or mutagens Category 3 under the Dangerous Preparations Directive criteria (pre-CLP). Substances with limited evidence or indications of carcinogenicity or mutagenicity.
Breast cancer ?
Substances classified with H362 phrase (may cause harm to breast-fed children). Toxic for reproduction due to effects on lactation or due to transmissibility through breast milk.
Restriction/prohibition regulations
Restricted substances REACH ?
Substances listed in Annex XVII of the REACH Regulation (EC) No 1907/2006, subject to restrictions on their manufacture, placing on the market or use. Restrictions may be total or partial, limiting specific applications, maximum concentrations or user groups.
Limitations:
Without prejudice to the other parts of this Annex the following shall apply to entries 28 to 30: 1. Shall not be placed on the market, or used,
- as substances,
- as constituents of other substances, or,
- in mixtures, for supply to the general public when the individual concentration in the substance or mixture is equal to or greater than:
- either the relevant specific concentration limit specified in Part 3 of Annex VI to Regulation (EC) No 1272/2008, or,
- the relevant concentration specified in Directive 1999/45/EC where no specific concentration limit is set out in Part 3 of Annex VI to Regulation (EC) No 1272/2008.
Without prejudice to the implementation of other Community provisions relating to the classification, packaging and labelling of substances and mixtures, suppliers shall ensure before the placing on the market that the packaging of such substances and mixtures is marked visibly, legibly and indelibly as follows: ‘Restricted to professional users’.
2. By way of derogation, paragraph 1 shall not apply to:
(a) medicinal or veterinary products as defined by Directive 2001/82/EC and Directive 2001/83/ EC;
(b) cosmetic products as defined by Directive 76/ 768/EEC;
(c) the following fuels and oil products:
- motor fuels which are covered by Directive 98/70/EC,
- mineral oil products intended for use as fuel in mobile or fixed combustion plants,
- fuels sold in closed systems (e.g. liquid gas bottles); (d) artists’ paints covered by Directive 1999/45/ EC;
(e) the substances listed in Appendix 11, column 1, for the applications or uses listed in Appendix 11, column
2. Where a date is specified in column 2 of Appendix 11, the derogation shall apply until the said date.
Source: Regulation 1907/2006 (REACH). Annex XVII
Substances under evaluation. PACT ?
Substances under active regulatory monitoring through ECHA's PACT (Public Activities Coordination Tool). Allows tracking which regulatory authorities are examining a substance and what potential regulatory actions are being considered (restriction, SVHC identification, harmonised classification, etc.).